Asthma and lower airway disease
House dust mite sensitization in toddlers predicts current wheeze at age 12 years

https://doi.org/10.1016/j.jaci.2011.06.038Get rights and content

Background

Identification of children at risk of developing asthma provides a window of opportunity for risk-reducing interventions. Allergen sensitization might identify high-risk children.

Objective

We sought to determine whether skin prick tests (SPTs) to individual allergens up to age 2 years predict wheeze at age 12 years.

Methods

In a birth cohort of 620 children oversampled for familial allergy, sensitization was assessed by using SPTs (monosensitized, polysensitized, or either) to 6 allergens at ages 6, 12, and 24 months. Wheeze and eczema were recorded 18 times during the first 2 years. Current wheeze was recorded at age 12 years. Adjusted associations were evaluated by multiple logistic regression.

Results

A positive SPT to house dust mite (HDM) at age 1 or 2 years predicted wheeze at age 12 years (adjusted odds ratio: 1 year, 3.31 [95% CI 1.59-6.91]; 2 years, 6.37 [95% CI, 3.48-11.66]). Among wheezy 1-year-olds, those who were HDM sensitized had a 75% (95% CI, 51% to 91%) probability of wheeze at age 12 years compared with a 36% (95% CI, 23% to 50%) probability among those not sensitized. Among eczematous 1-year-olds, those who were HDM sensitized had a 67% (95% CI, 45% to 84%) probability of wheeze at age 12 years compared with a 35% (95% CI, 25% to 45%) probability among those not sensitized. Among 1-year-old children with both eczema and wheeze, the probability of wheeze at age 12 years was 64% (95% CI, 35% to 87%) if HDM sensitized and 50% (95% CI, 26% to 74%) if not.

Conclusion

HDM sensitization at age 1 or 2 years in wheezing and eczematous children at increased familial allergy risk predicts asthma and may inform management of these high-risk groups.

Section snippets

Study population

The Melbourne Atopy Cohort study (MACS) is a longitudinal, birth cohort study comprising 620 babies enrolled before birth by recruiting pregnant women living in Melbourne, Australia. Eligible babies had at least 1 first-degree family member with a history of eczema and/or asthma and/or allergic rhinitis and/or severe food allergy. The 620 children were born between March 24, 1990, and November 1, 1994.

Data collection

An allergy-trained research nurse conducted telephone surveys with the babies’ mothers every 4

Results

Baseline demographics of MACS have already been published.21, 22, 23, 24 Briefly, parents of the MACS cohort were predominantly well educated (59% of mothers and 61% of fathers attended university), Australian born (87% of mothers and 83% of fathers), and of high socioeconomic status (4% of mothers and 3% of fathers were receiving social security benefits at baseline). More than half (51%) of the participants were male, and all children had at least 1 immediate family member with “allergic

Discussion

Our study showed HDM sensitization was associated with current wheeze at age 12 years in both monosensitized and polysensitized HDM-sensitized children. However, we were unable to derive any conclusions on similar associations in relation to other single allergens tested in this study because of the small number of positive SPT responses. Furthermore, when we considered children with sensitization profiles excluding HDM, we were unable to demonstrate an association with 12-year wheeze,

References (42)

  • S. Illi et al.

    The pattern of atopic sensitization is associated with the development of asthma in childhood

    J Allergy Clin Immunol

    (2001)
  • R. Voorhorst et al.

    The house-dust mite (Dermatophagoides pteronyssinus) and the allergens it produces: identity with the house dust allergen

    J Allergy

    (1967)
  • M. Masoli et al.

    The global burden of asthma: executive summary of the GINA Dissemination Committee Report

    Allergy Asthma Proc

    (2004)
  • F.D. Martinez et al.

    Asthma and wheezing in the first six years of life

    N Engl J Med

    (1995)
  • R.J. Kurukulaaratchy et al.

    Defining childhood atopic phenotypes to investigate the association of atopic sensitization with allergic disease

    Allergy

    (2005)
  • P.M. Matricardi et al.

    Dynamic evolution of serum immunoglobulin E to airborne allergens throughout childhood: results from the Multi-Centre Allergy Study birth cohort

    Clin Exp Allergy

    (2009)
  • N. Ghunaim et al.

    Sensitization to different pollens and allergic disease in 4-year-old Swedish children

    Clin Exp Allergy

    (2006)
  • M.R. Sears et al.

    A longitudinal, population-based, cohort study of childhood asthma followed to adulthood

    N Engl J Med

    (2003)
  • A. Bierg-Bäcklund et al.

    Asthma during the primary school ages—prevalence, remission and the impact of allergic sensitization

    Allergy

    (2006)
  • R. Sporik et al.

    Allergen exposure and the development of asthma

    Thorax

    (2001)
  • M.I. Asher et al.

    International study of asthma and allergies in childhood (ISAAC): rationale and methods

    Eur Respir J

    (1995)
  • Cited by (103)

    • Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective

      2024, Journal of Allergy and Clinical Immunology: In Practice
    • Immunologic Strategies for Prevention of Asthma

      2020, Journal of Allergy and Clinical Immunology: In Practice
    • Epidemiology and risk factors for asthma

      2019, Respiratory Medicine
      Citation Excerpt :

      This resulted in several key environmental observations, such as the association of cockroach, dust mite, and mouse sensitization with uncontrolled asthma [29]. In a pediatric cohort, dust mite sensitization at ages 1 and 2 were predictive of 3.3- and 6.4-times odds of wheezing at follow up in adolescence [30]. Two separate birth cohorts of at-risk children demonstrated a significant dose-response relationship between HDM exposure and related atopic asthma [31,32].

    View all citing articles on Scopus

    Initial support for the study was from Nestlé Australia, and the 12-year follow-up was supported by the Asthma Foundation of Victoria. C.J.L. is supported by the Sidney Myer Health Fund and the National Health and Medical Research Council of Australia (NHMRC). A.J.L., L.C.G., J.L.H., M.C.M., and S.C.D. are supported by the NHMRC. K.J.A. is supported by the Charles and Sylvia Viertel Charitable Foundation.

    Disclosure of potential conflict of interest: M. J. Abramson was part of the Landmark Symposium for GlaxoSmithKline and receives research support from Reckitts Benckiser. D. Hill has received past support from Nutricia, SHS International, and Nestlé for research, and has presented lectures at sponsored meetings. The rest of the authors have declared that they have no conflict of interest.

    View full text